Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of ...

Wegovy and Ozempic, both known chemically as semaglutide, were until recently in shortage in the US Although all dose ...

Novo Nordisk posted solid quarterly results Wednesday before the market open.The drug maker’s sales came in at 71.3 billion ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs ...

Novo Nordisk latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...

But this fairly new diabetes drug seems to have a few more tricks up its sleeve. New research has found that Ozempic (or ...

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...

Novo Nordisk's valuation remains high, trading at a significant historical premium. Click here to see why NVO stock is a Sell ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

What is ageing? Ageing is a highly complex biological process. Our DNA is constantly being broken down and repaired. An ...